跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 317 条关于
“TLX591-Tx”
全部
317
临床试验
163
药物
54
机构
40
资讯
60
2个月前
Telix Opens Australia's First Integrated Radiopharmaceutical Facility to Accelerate Cancer Theranostics
前天
FDA Approves Telix's Pixclara, First FET-PET Imaging Drug for Glioma in the U.S.
去年
Phase 3 ProstACT GLOBAL Trial Assesses 177Lu-TLX591 in Metastatic Castration-Resistant Prostate Cancer
2年前
Telix Pharmaceuticals Doses First Patient in Phase III ProstACT GLOBAL Study of TLX591 for Prostate Cancer
去年
Novamigra Tx Advances Migraine Therapy with FDA's Endorsement for Accelerated Clinical Development
10个月前
Castle Biosciences Launches AdvanceAD-Tx Gene Expression Test to Guide Atopic Dermatitis Treatment Selection
去年
Supernus' SPN-820 Shows Promise as Rapid-Onset Depression Treatment
去年
Baylor College of Medicine Partners with Site Tx to Advance Immune-Targeted Small Molecule Drug Discovery
去年
Tanvex Biopharma Receives Second CRL from FDA for Herceptin Biosimilar TX-05
9个月前
Telix Pharmaceuticals Advances ProstACT Global Phase 3 Trial with First Patient Dosed in Randomized Expansion
第 1 页,共 6 页
上一页
下一页